Not checked for notices yet.
Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
Abdelrahman Ibrahim Abushouk, Ahmed Elmaraezy, Amro Aglan and 4 more
BMC Neurology · 2017
Cited by papers we hold 1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.